You're reading the free version. Trader adds the live tape and alerts.
Start tracking
GALT Sale Disclosure
Jamil Khurram · SEC Form 4 · Filed Jun 30, 2026
Sale
Calculated transaction value
$239.23K
Jamil Khurram Chief Medical Officer
GALT
Transaction date
Jun 29, 2026
Public filing date
Jun 30, 2026
Filing lag
Filed 1 day later
GALT daily price context
Close on/before transaction
$4.97
Jun 29, 2026
First close after public filing
$4.33
Jul 1, 2026
30-day return after filing
-25.4%
Through Jul 30, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 47,467 shares @ $5.04
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001133416-26-000059
Filing cohort
Transactions in this filing
Showing 9 of 9
Trades
9
Issuers
1
Estimated value
$391.57K
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Galectin Therapeutics Inc GALT | Exercise | Jun 29, 2026 | $0 |
| Galectin Therapeutics Inc GALT | Exercise | Jun 29, 2026 | $118.67K |
| Galectin Therapeutics Inc GALT Current | Sale | Jun 29, 2026 | $239.23K |
| Galectin Therapeutics Inc GALT | Exercise | Jun 26, 2026 | $0 |
| Galectin Therapeutics Inc GALT | Exercise | Jun 26, 2026 | $6.33K |
| Galectin Therapeutics Inc GALT | Sale | Jun 26, 2026 | $12.66K |
| Galectin Therapeutics Inc GALT | Sale | Jun 26, 2026 | $10.19K |
| Galectin Therapeutics Inc GALT | Exercise | Jun 26, 2026 | $0 |
| Galectin Therapeutics Inc GALT | Exercise | Jun 26, 2026 | $4.48K |